Pegylated Interferon for the Adjuvant Treatment of Melanoma: FDA Approved, but What Is Its Role?

Authors

Vernon K. Sondak, University of South FloridaFollow
Ragini Kudchadkar, University of South Florida

Document Type

Article

Publication Date

2012

Digital Object Identifier (DOI)

https://doi.org/10.1634/theoncologist.2012-0368

Citation / Publisher Attribution

The Oncologist, v. 17, issue 10, p. 1223-1224

Scholar Commons Citation

Sondak, Vernon K. and Kudchadkar, Ragini, "Pegylated Interferon for the Adjuvant Treatment of Melanoma: FDA Approved, but What Is Its Role?" (2012). Oncologic Sciences Faculty Publications. 28.
https://digitalcommons.usf.edu/onc_facpub/28

Was this content written or created while at USF?

Yes